Testing delivery of components of cognitive behavioral therapy for insomnia to breast cancer survivors by smart speaker: a study protocol.
Testing delivery of components of cognitive behavioral therapy for insomnia to breast cancer survivors by smart speaker: a study protocol.
复制标题
DOI：
10.1186/s12911-022-01902-w
复制
发表时间：
2022-06-21
影响因子：
3.5
通讯作者：
Arem, Hannah
中科院分区：
文献类型：
--
作者：
Starling, Claire M.;Greenberg, Daniel;Zhou, Eric;Lewin, Daniel;Morrow, Allison S.;Lieberman, Daniel;Shaw, Callen;Arem, Hannah
乳腺癌幸存者（BCS）中的乳腺癌是常见的，在美国380万BCS中估计有30-50%受到影响。胰岛素抵抗与心脏代谢和免疫系统、神经行为功能、抑郁、疲劳和生活质量的健康后果相关，并可能使BCS处于特别危险的境地。虽然失眠的药物治疗可以在短期内解决症状，但失眠的认知行为疗法（CBT-I）被认为是失眠治疗的金标准。我们描述了我们的协议，以确定CBT-I组件的语音激活交付失眠症状的疗效相比，BCS之间的睡眠教育控制。我们将进行一项为期6周的随机对照试验，分为两组。干预组参与者将收到一个智能扬声器设备，并将被要求每天使用带有智能手机应用程序的声控扬声器参与该计划。对照组参与者将可以访问一个网站，其中包含有关CBT-I，睡眠和乳腺癌生存率的基本信息，并将被要求根据需要参与该网站。我们的主要结果是Insulin严重程度指数总分。次要结果包括睡眠日记结果（睡眠效率、入睡后觉醒、入睡潜伏期、总睡眠时间和睡眠质量）。这项研究将提供证据的一个有前途的方式，提供CBT-I的BCS经历失眠的元素。试用注册ClinicalTrials.gov NCT 05233800已发布3/25/2022.
Insomnia is common in breast cancer survivors (BCS), affecting an estimated 30–50% of the 3.8 million BCS in the US. Insomnia is associated with health consequences for cardiometabolic and immune systems, neurobehavioral function, depression, fatigue, and quality of life and may put BCS at particular risk. While pharmacotherapy for insomnia may address symptoms in the short-term, cognitive behavioral therapy for insomnia (CBT-I) is considered the gold standard insomnia treatment. We describe our protocol to determine the efficacy of voice-activated delivery of CBT-I components on insomnia symptoms compared to a sleep education control among BCS. We will conduct a 6-week, randomized controlled trial with two arms. Intervention arm participants will receive a smart speaker device and will be asked to engage with the program daily, using a voice-activated speaker with an accompanying smart-phone app. Control participants will have access to a website with basic information about CBT-I, sleep, and breast cancer survivorship and will be asked to engage with the website as desired. Our primary outcome is the Insomnia Severity Index total score. Secondary outcomes include sleep diary outcomes (sleep efficiency, wake after sleep onset, sleep onset latency, total sleep time, and sleep quality). This study will provide evidence on a promising modality to deliver elements of CBT-I for BCS experiencing insomnia. Trial Registration ClinicalTrials.gov NCT05233800 Released 3/25/2022.
登录
查看更多内容
影响因子：
2.7
作者：
Zhou, Eric S.;Clark, Karen;Loscalzo, Matthew
通讯作者：
Loscalzo, Matthew
影响因子：
5.6
作者：
Espie, Colin A.;Kyle, Simon D.;Brown, June S. L.
通讯作者：
Brown, June S. L.
影响因子：
4.3
作者：
Edinger, Jack D.;Arnedt, J. Todd;Martin, Jennifer L.
通讯作者：
Martin, Jennifer L.
DOI：
10.1016/j.invent.2017.03.005
发表时间：
2017-09-01
影响因子：
4.3
作者：
Dozeman, Els;Verdonck-de Leeuw, Irma M.;van Straten, Annemieke
通讯作者：
van Straten, Annemieke
影响因子：
2.8
作者：
Arem, Hannah;Scott, Remle;Lewin, Daniel
通讯作者：
Lewin, Daniel